Guided Therapeutics (GTHP) Receivables - Net (2016 - 2025)
Guided Therapeutics (GTHP) has disclosed Receivables - Net for 16 consecutive years, with $4000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 33.33% to $4000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4000.0 through Dec 2025, up 33.33% year-over-year, with the annual reading at $4000.0 for FY2025, 33.33% up from the prior year.
- Receivables - Net hit $4000.0 in Q4 2025 for Guided Therapeutics, down from $6000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $155046.0 in Q2 2022 to a low of $2000.0 in Q2 2024.
- Historically, Receivables - Net has averaged $51071.8 across 5 years, with a median of $7721.0 in 2023.
- Biggest five-year swings in Receivables - Net: skyrocketed 425.0% in 2021 and later tumbled 95.49% in 2023.
- Year by year, Receivables - Net stood at $126000.0 in 2021, then tumbled by 61.9% to $48000.0 in 2022, then tumbled by 84.5% to $7442.0 in 2023, then plummeted by 59.69% to $3000.0 in 2024, then skyrocketed by 33.33% to $4000.0 in 2025.
- Business Quant data shows Receivables - Net for GTHP at $4000.0 in Q4 2025, $6000.0 in Q3 2025, and $8000.0 in Q2 2025.